DUBLIN–(BUSINESS WIRE)–The “Conjunctivitis (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Conjunctivitis (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Conjunctiviti…
Author: Business Wire
Eye Health America Acquires Nielsen Eye Center
CLEARWATER, Fla. & LARGO, Fla.–(BUSINESS WIRE)–Eye Health America (EHA) is proud to announce the acquisition of Nielsen Eye Center. Nielsen Eye Center is joining Updegraff Laser Vision to expand Eye Health America’s continuum of patient care in the T…
Eye Health America Announces Newest Acquisition of Eye Centers of Florida
FT. MYERS, Fla.–(BUSINESS WIRE)–Eye Health America (EHA), a leading eyecare provider, announced today the acquisition of Eye Centers of Florida, the company’s eighth acquistion of 2021. Based in Ft. Myers, FL., Eye Centers of Florida (ECOF) is a high…
Glaukos Announces Participation in the Wells Fargo Healthcare Conference
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that …
EyeSouth Partners Expands Network in South Florida Through Addition of Dr. James Guildford
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce the addition of Dr. James H. Guildford, M.D. based in West Palm Beach, Florida. As part of the addition, Dr. Guildford will join Retina Care Specialists in…
Texan Eye Enters Partnership with Comprehensive EyeCare Partners
LAS VEGAS & AUSTIN, Texas–(BUSINESS WIRE)– #Financials–Comprehensive EyeCare Partners (CompEye), one of the largest vision care practice management organizations in the nation, is pleased to announce a strategic partnership with Texan Eye, a leading…
Visus Therapeutics Appoints Industry Leaders Tracy Valorie and Dwight Moxie to Board of Directors
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics Inc., a clinical-stage pharmaceutical company developing innovative ophthalmic therapies to improve vision for people around the world, today announced the appointments of Tracy Valorie, former Senior Vice P…
Warby Parker Announces Public Filing of Registration Statement for Proposed Direct Listing of its Class A Common Stock
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. today announced that it has publicly filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) relating to the proposed public listing of its Class A common stock. Th…
Zenni Introduces the “Iris Apfel Zentennial Collection,” Designed by the Style Icon Herself in Celebration of Her 100th Birthday
NOVATO, Calif.–(BUSINESS WIRE)–Zenni, the online eyewear retail leader, today announced the launch of a new fashion eyewear capsule, the “Iris Apfel Zentennial Collection,” designed exclusively for Zenni by the beloved fashion icon, world famous eyew…
Fuchs Endothelial Corneal Dystrophy (Ophthalmology) Pipeline Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy (FECD) (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Fuchs Endothelial Corneal Dystrophy (FECD) (Ophthalmology) – Drugs in Dev…
Ocular Melanoma (Oncology) Pipeline Landscape Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Melanoma (Oncology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Ocular Melanoma (Oncology) – Drugs in Development, 2021 provides an overview of the Ocular Melanoma pipel…
Glaukos Announces Market-Leading Clinical Milestone of 200 Peer-Reviewed Publications on iStent® Technologies
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today an un…
Global Optic Neuropathy (Ophthalmology) Drugs In Development 2021 Market Report – Featuring Antoxis, Astellas Pharma and Quark Pharmaceuticals – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuropathy (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. Optic …
Allergic Rhino-Conjunctivitis (Ophthalmology) Drugs in Development, 2021 Research Report – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Allergic Rhino-Conjunctivitis (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Allergic Rhino-Conjunctivitis (Ophthalmology) – Drugs in Development, 2021 provides an…
Myopia (Ophthalmology) Drugs Development Research Report 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Myopia (Ophthalmology) – Drugs in Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Myopia (Ophthalmology) – Drugs in Development, 2021 provides an overview of the Myopia pipeline landscape. Th…
2020 On-site Completes Observational Study that Confirms Eye Exams in Mobile Settings Have Same Results as In-Office Exams
BOSTON–(BUSINESS WIRE)–2020 On-site has completed its observational study to assess the quality of data in a mobile eye setting.
Endace Celebrates 20th Anniversary With Donation to The Glaucoma Foundation
AUCKLAND, New Zealand & NEW YORK–(BUSINESS WIRE)– #TGF_Glaucoma–To celebrate our 20th anniversary, Endace is donating to the 2021 TGF Art Challenge to benefit Glaucoma research and treatment.
Visus Therapeutics Expands Ophthalmic Drug Portfolio With Investigational Therapies for Glaucoma and Age-related Macular Degeneration; Secures Exclusive License for Novel Ophthalmic Drug Delivery Technology
SEATTLE–(BUSINESS WIRE)–Visus Therapeutics expands ophthalmic drug portfolio with investigational therapies for glaucoma and age-related macular degeneration.
Sonoma Pharmaceuticals Announces Expanded Dental Care Line with a New Product for Professional Care in the U.S. and a New Product for Professional and Consumer Care in Switzerland
WOODSTOCK, Ga.–(BUSINESS WIRE)–Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, includi…
NovaBay Pharmaceuticals to Distribute Zocular® Dry Eye Products
EMERYVILLE, Calif. & CYPRESS, Texas–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova for the eye care market, announces an agreement with Okra Limited to distribute thei…